Quantcast

Latest Cytomegalovirus Stories

2010-05-04 13:33:39

A national study involving a UT Southwestern Medical Center neonatologist and pediatric infectious diseases specialist suggests that a screening test routinely performed in newborns is not very good at identifying cytomegalovirus (CMV) infection, a leading cause of hearing loss in children. The findings, published in the April 14 issue of the Journal of the American Medical Association, suggest that testing blood drawn from a newborn's heel has limited value in detecting CMV infection. The...

2010-05-04 07:30:00

RESEARCH TRIANGLE PARK, N.C., May 4 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced today that Kenneth I. Moch has been appointed President and Chief Executive Officer. Mr. Moch joined Chimerix as Chief Operating Officer in July 2009, bringing more than 25 years of experience in creating, managing and financing biomedical companies. Mr. Moch will also join the company's Board, for a total of six directors. George...

d5265f0b60fe30a24d5122c06af9b8b6
2010-04-02 11:21:54

A study published in this week's online edition of Science has uncovered how the cytomegalovirus (CMV) is able to re-infect people in spite of the presence of a strong immune response. Research conducted at the Oregon Health & Science University (OHSU) Vaccine and Gene Therapy Institute (VGTI) showed that CMV re-infection can only take place when the virus invades a specific type of white blood cell--the CD8+ T cells--which attack and kill infected cells. "CMV is one of a few virus types...

2010-03-09 07:30:00

RESEARCH TRIANGLE PARK, N.C., March 9 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced the initiation of a multi-center Phase 2 clinical trial designed to evaluate CMX001 in stem cell transplant recipients who are seropositive for cytomegalovirus (CMV). CMX001 is a broad-spectrum antiviral agent with demonstrated activity against double-stranded DNA (dsDNA) viruses. The Phase 2 randomized, double-blind,...

2010-02-23 07:30:00

RESEARCH TRIANGLE PARK, N.C., Feb. 23 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced today that founder and CEO George Painter, Ph.D., will join representatives from government, industry and academia in an Institute of Medicine Workshop focusing on improving innovation around the discovery and development of new products needed to undertake medical countermeasures (e.g. vaccines, drugs, and diagnostics) when...

2010-02-11 10:36:00

WASHINGTON, Feb. 11 /PRNewswire-USNewswire/ -- Patient Access Network (PAN) Foundation will expand its services to provide co-payment assistance for medications to underinsured patients through five new funds -- including grants of up to $10,000 per year for prostate cancer patients. The other new funds will provide access to medications for patients with hepatitis B or C, non-kidney solid organ transplants, cytomegalovirus (or CMV), and acromegaly. These new funds are an expansion of...

2010-02-04 07:30:00

RESEARCH TRIANGLE PARK, N.C., Feb. 4 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, announced today that Gwendolyn Powell Painter, M.D., M.P.H., has joined the company as Chief Medical Officer. Dr. Painter has more than 20 years of experience in the pharmaceutical industry, including work in clinical development, clinical safety and pharmacovigilance, and occupational and environmental medicine. In her role as Chief Medical...

2009-12-07 19:26:31

A new study shows that people who have been infected with West Nile virus may have persistent virus in their kidneys for years after initial infection, potentially leading to kidney problems. The research, which appears in the January 1 issue of The Journal of Infectious Diseases, is now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/648731). Spread by infected mosquitoes, West Nile virus was first detected in the United States in 1999. Since then, approximately 25,000...

2009-11-06 07:30:00

RESEARCH TRIANGLE PARK, N.C., Nov. 6 /PRNewswire/ -- Chimerix, Inc., a biopharmaceutical company advancing orally-available antiviral therapeutics to address life-threatening diseases, presented updates on the development of the company's lead antiviral compound, CMX001, to the World Health Organization (WHO) and the Global Health Security Initiative (GHSI). CMX001 is a broad-spectrum antiviral agent being developed for the treatment of smallpox, as well as other serious viral infections....

2009-10-21 12:23:10

Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus infection exacerbates experimental colitis," appears in the November 2009 issue of The American Journal of Pathology. CMV infects between 50% and 80% of adults in the United States. Most people who are infected have no symptoms, and the virus remains hidden but inactive in the body for the rest of the person's...


Latest Cytomegalovirus Reference Libraries

0_bbd337098cfaf28eafeb5f5f010e48ef
2011-01-12 15:30:34

Cytomegalovirus, a herpes viral genus, is known in humans as HCMV. It is part of the Betaherpesvirinae subfamily. Other herpesviruses fall into the subfamilies of Alphaherpesvirinae or Gammaherpesvirinae. xHCMV infections are frequently associated with salivary glands. It can be lethal for people who are immunocompromised. Other CMV viruses are found in several mammal species, but species isolated from animals differ from HCMV in terms of genomic structure. HCMV is found all over the...

More Articles (1 articles) »
Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related